Gsk (GLAXF) Equity Income (2018 - 2025)
Historic Equity Income for Gsk (GLAXF) over the last 9 years, with Q3 2025 value amounting to $5.4 million.
- Gsk's Equity Income rose 51531.52% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.4 million, marking a year-over-year increase of 7586.93%. This contributed to the annual value of -$3.8 million for FY2024, which is 3833.81% up from last year.
- Latest data reveals that Gsk reported Equity Income of $5.4 million as of Q3 2025, which was up 51531.52% from -$2.7 million recorded in Q2 2025.
- In the past 5 years, Gsk's Equity Income ranged from a high of $5.4 million in Q3 2025 and a low of -$6.2 million during Q4 2023
- Over the past 4 years, Gsk's median Equity Income value was -$2.3 million (recorded in 2022), while the average stood at -$1.8 million.
- As far as peak fluctuations go, Gsk's Equity Income plummeted by 16454.13% in 2023, and later soared by 51531.52% in 2025.
- Quarter analysis of 4 years shows Gsk's Equity Income stood at -$2.3 million in 2022, then tumbled by 164.54% to -$6.2 million in 2023, then surged by 37.95% to -$3.9 million in 2024, then soared by 240.14% to $5.4 million in 2025.
- Its Equity Income was $5.4 million in Q3 2025, compared to -$2.7 million in Q2 2025 and -$3.9 million in Q4 2024.